Webinar: Myocardial Protection: Adult and Pediatric Heart Transplantation
About the Event
An ischemic time period of 4 hours is used as the acceptable threshold for clinical heart transplantation in many centers. The preservation solutions used for storage of donor hearts during this period vary by heart transplant centers both nationally and internationally. The limitations of mechanical arrest and hypothermic preservation combined with other clinical challenges can contribute to primary graft dysfunction (PGD), which accounts for the majority of deaths after heart transplant. Preservation solutions can be broadly categorized as intracellular and extracellular solutions. The Universities of Giessen and Sao Paolo heart transplant programs have used histidine-tryptophan-ketoglutarate [HTK] solution exclusively for donor heart preservation since decades, which represents a real-world experience with this intracellular preservation solution protection. In March 2025 our experts discussed both adult and pediatric cardiac preservation.
For more information visit the Köhler Campus platform at www.koehler-campus.com/webinar-11-03-2025/
Prof. Dr. Ronaldo Honorato Barros Santos
Cardiothoracic Department – Cardiovascular Surgery Division – Heart Institute – University of São Paulo Medical School Heart Institute – University of São Paulo Medical School, Brazil
Associate Professor Dr. med. Mohamed Salem, MaHM
Specialist in Cardiac Surgery Department of Pediatric Cardiac Surgery and Congenital Heart Defects at the University Hospital Gießen and Marburg, Germany